PFM Health Sciences’s BCLS Acquisition Corp. Class A Ordinary Shares BLSA Stock Holding History

PFM Health Sciences’s Portfolio BLSA Stock Details BLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-464,103	Closed	-$4.65M	–	105
2022 Q3	$4.65M	Hold	464,103	–	–	0.17%	74
2022 Q2	$4.59M	Hold	464,103	–	–	0.18%	75
2022 Q1	$4.58M	Hold	464,103	–	–	0.17%	63
2021 Q4	$4.55M	Hold	464,103	–	–	0.15%	66
2021 Q3	$4.64M	Hold	464,103	–	–	0.14%	77
2021 Q2	$4.89M	Hold	464,103	–	–	0.15%	78
2021 Q1	$4.91M	Sell	464,103 -35,897	-7%	-$405K	0.15%	81
2020 Q4	$5.51M	Buy	+500,000	New	+$5.36M	0.19%	78

PFM Health Sciences's BLSA Position: Q4 2022 in Review

PFM Health Sciences sold out of BCLS Acquisition Corp. Class A Ordinary Shares (BLSA) in Q4 2022, closing a stake of 464,103 shares — an estimated $4.65M sold.

PFM Health Sciences first reported a position in BLSA in Q4 2020 and held it in 8 quarters. The position peaked at $5.51M in Q4 2020. 0 funds tracked by Wall St. Rank hold BLSA as of Q4 2022.

PFM Health Sciences reported no remaining BCLS Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
PFM Health Sciences sold 464,103 BCLS Acquisition Corp. Class A Ordinary Shares shares in Q4 2022, an estimated $4.65M.
PFM Health Sciences first reported a position in BCLS Acquisition Corp. Class A Ordinary Shares in Q4 2020 and held it in 8 quarters.
PFM Health Sciences's BCLS Acquisition Corp. Class A Ordinary Shares position peaked at $5.51M in Q4 2020.
0 funds tracked by Wall St. Rank held BCLS Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on PFM Health Sciences's 13F filing for Q4 2022, filed 14 Feb 2023.